Plasma BNP and HCY and serum IGF-1 levels can well predict the changes and severity of cardiac function in elderly patients with chronic CHF, dynamic monitoring of plasma BNP and HCY and serum IGF-1 levels, and early clinical development of corresponding anti-heart failure treatment measures and rescue plans. Here, NPPB is linked to heart failure.